A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

Strategic acquisition marks significant step to establish pan-European footprint and deepens expertise in oncology and early-phase biotech clinical trials.

Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...

Plus: Rockville man arrested for filming woman in fitting room at Montgomery mall; Montgomery College launches cybersecurity ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

'You could get burned': Insurers warned as naïve players flood Canada's booming life sciences market This article was created ...

The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who ...

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Fierce 15 nominations are open! We're searching for the most innovative, resourceful and visionary biotechs leading the way ...